Altamira Therapeutics Ltd. (CYTO) Under Corrections Premarket After Huge Uptick on Covid-19 Nasal Spray Data
Yesterday, Altamira Therapeutics Ltd. (CYTO) saw a huge uptick after it announced the publication of its Covid-19 nasal spray data in IJMS. The stock rallied by over 55% in the regular trading session to mark the close of the day at $1.66 apiece. In today’s premarket session on April 12, CYTO has succumbed to corrections […]